1 / 10Mankind Pharma | Beige Ltd, an affiliate of private equity firm ChrysCapital, is likely to sell up to 2.90% of its stake in the drug firm through block deals, offering shares at a price range of ₹2,103-₹2,214, sources privy to the development told CNBC-TV18. The deal is estimated to be worth ₹2,460 crore, according to multiple people familiar with the development.
2 / 10Vedanta | Mining conglomerate said it will invest $6 billion across businesses that span from aluminium and zinc to iron ore, steel and oil and gas as it looks to add at least $2.5 billion to annual EBITDA, its executives said in an investor meeting. It has a pipeline of more than 50 active projects and expansions to drive growth, which is expected to generate incremental revenue of over $6 billion, they added.
3 / 10Bajaj Auto | Leading two-wheeler maker is gearing up to launch its most substantial addition to the Pulsar lineup yet. Sources close to the company told CNBC-TV18 that the launch of the "biggest Pulsar" has been scheduled for May 3.- Additionally, the company plans to introduce a CNG-powered motorcycle variant on June 18, the sources said.
4 / 10Lupin | Pharma major said the company is planning to carve out its trade generics business in India and transfer it to Lupin Life Sciences Ltd (LLSL), a wholly-owned subsidiary of the company, for ₹100-120 crore. The business transfer agreement (BTA) between Lupin and LLSL is expected to be finalised in Q1 of FY25.
5 / 10Ambuja Cements | Adani Group-owned entity sold a 2% stake in Sanghi Industries Ltd for ₹258.32 crore to achieve minimum public shareholding. With this, Ambuja Cements’ stake in Sanghi Industries has come down to 60.44% from 62.44%. With this, Ambuja Cements’ stake in Sanghi Industries has come down to 60.44% from 62.44%.
6 / 10Dr Reddy's | Pharma major said it has entered into a licence agreement with US-based Pharmazz Inc, to commercialise the first-in-class innovative drug centhaquine in India. Developed by Pharmazz, centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by the Drugs Controller General of India (DCGI), according to a stock exchange filing.
7 / 10Fortis Healthcare | Healthcare major said Fortis Hospitals Ltd, a material subsidiary of the company, has received an income tax assessment order, demanding ₹89.53 crore (including interest of ₹9.54 crore). "The company is evaluating the said order and will take appropriate actions in due course," according to a stock exchange filing.
8 / 10Uno Minda | Auto components maker said the company has entered into a technical licence agreement (TLA) with Starcharge Energy Pte Ltd for the manufacture and sale of wall-mounted AC chargers designed for convenient home charging, in India. These chargers are usually sold along with electric vehicles to the customers by the OEMs to provide ease of charging at home.
9 / 10Hinduja Global Solutions | Business process management firm said it has entered into an agreement to sell its optical fibre assets to its subsidiary, Indusind Media and Communications Ltd (IMCL), for ₹208.04 crore. IMCL is a subsidiary of HGSL, with HGSL holding a 77.55% share capital in IMCL, making it a related party.
10 / 10ICICI Securities | Brokerage house said it has received an administrative warning from SEBI regarding its Merchant Banking activities. The warning was issued through an email dated March 22, 2024, which the company received at 4:06 PM. The warning comes in connection with SEBI's inspection of the books and records related to ICICI Securities' Merchant Banking activities, conducted in December 2023.
